DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030 USD 1034.78 BN MARKET SIZE, 2030 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The injectable drug delivery market is projected to reach USD 1,034.78 billion by 2030 from USD 690.23 billion in 2025, at a CAGR of 8.4% from 2025 to 2030
While not a primary concern, understanding sweatings relationship to Wegovy empowers patients to distinguish between expected responses and situations requiring medical attention
That does not mean it never happens
This rise in reported overdoses may influence ongoing litigation regarding GLP-1 drugs, where plaintiffs claim that manufacturers did not sufficiently warn about serious gastrointestinal and metabolic risks
doi:10.3390/ijms25084346 Ghusn W, De la Rosa A, Sacoto D, et al
Sermorelin, CJC-1295/Ipamorelin, and tesamorelin are indirect growth-hormone-axis peptides, not primary testosterone drugs